Letter to the Editor Low Prevalence of Chronic Hypertransaminasemia in a Cohort of HIV-Infected Patients with No Coinfections

non-alcoholic fatty liver disease Liver disease is very common in patients with HIV infection.1 The association between chronic infection with hepatotropic viruses and being a target for other diseases, such as opportu-nistic infections and tumors, nonalcoholic fatty liver disease (NAFLD), and toxicity to drugs, including antiretroviral ther-apy (ART), results in liver disease being a leading cause of morbidity and mortality in these persons.1 The aim of this study was to determine the prevalence of chronic hypertransaminasemia (CHT) in a cohort of patients with HIV infection but no coinfection and to examine the factors associated with CHT. We undertook a cross-sectional, case-control study of all HIV-infected patients who regularly attended the infectious diseases office of our center from March to August 2009